SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-222410
Filing Date
2013-05-15
Accepted
2013-05-15 16:18:03
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d516703d10q.htm 10-Q 342213
2 EX-31.1 d516703dex311.htm EX-31.1 9134
3 EX-31.2 d516703dex312.htm EX-31.2 9119
4 EX-32.1 d516703dex321.htm EX-32.1 3902
5 EX-32.2 d516703dex322.htm EX-32.2 3887
  Complete submission text file 0001193125-13-222410.txt   3256900

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20130331.xml EX-101.INS 423458
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20130331.xsd EX-101.SCH 39796
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20130331_cal.xml EX-101.CAL 46453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20130331_def.xml EX-101.DEF 104306
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20130331_lab.xml EX-101.LAB 275091
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20130331_pre.xml EX-101.PRE 194103
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 13847353
SIC: 2834 Pharmaceutical Preparations